Before revision:  We make the prioritized list of human proteins and drug targets broadly available as a general resource for repositioning of existing and approved drugs  as anti-COVID-19 agents or for novel drug development .
After revision:  We make the prioritized list of human proteins and drug targets broadly available as a general resource for repositioning of existing and approved drugs or developing novel therapeutics as anti-COVID-19 agents or for novel drug development .